Precision Biosciences (DTIL) Profit After Tax (2018 - 2026)
Precision Biosciences (DTIL) reported Profit After Tax of -$18.4 million for Q1 2026, up 10.33% year-over-year from -$16.7 million in Q1 2025, and down 195.81% quarter-over-quarter from $19.2 million in Q4 2025.
Precision Biosciences (DTIL) Profit After Tax (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Profit After Tax data on file, last reported at -$18.4 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$18.4 million, up 10.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$44.5 million (down 102.33% YoY), and the FY2025 annual result was -$46.6 million, down 750.33% from the prior year.
- Profit After Tax slipped to -$18.4 million in Q1 2026 per DTIL's latest filing, from $19.2 million in the prior quarter.
- Over five years, Profit After Tax peaked at $32.7 million in Q2 2024 and troughed at -$58.2 million in Q4 2022.
- A 5-year average of -$15.1 million and a median of -$17.7 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax soared 375.41% in 2024, then sank 339.46% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$58.2 million in 2022, then jumped by 71.99% to -$16.3 million in 2023, then slipped by 8.94% to -$17.7 million in 2024, then soared by 208.47% to $19.2 million in 2025, then slumped by 195.81% to -$18.4 million in 2026.
- Business Quant data shows DTIL's Profit After Tax at -$18.4 million in Q1 2026, $19.2 million in Q4 2025, and -$21.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.44 Mn |
| Dec 31, 2025 | 19.25 Mn |
| Sep 30, 2025 | -21.77 Mn |
| Jun 30, 2025 | -23.52 Mn |
| Mar 31, 2025 | -20.57 Mn |
| Dec 31, 2024 | -17.75 Mn |
| Sep 30, 2024 | -16.43 Mn |
| Jun 30, 2024 | 32.75 Mn |
| Mar 31, 2024 | 8.59 Mn |
| Dec 31, 2023 | -16.29 Mn |
| Sep 30, 2023 | -12.11 Mn |
| Jun 30, 2023 | -11.89 Mn |
| Mar 31, 2023 | -25.06 Mn |
| Dec 31, 2022 | -58.16 Mn |
| Sep 30, 2022 | -15.69 Mn |
| Jun 30, 2022 | -31.04 Mn |
| Mar 31, 2022 | -28.17 Mn |
| Dec 31, 2021 | -22.29 Mn |
| Sep 30, 2021 | -11.28 Mn |
| Jun 30, 2021 | 21.66 Mn |